Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas
Oncotarget
.
2018 Mar 13;9(19):15165.
doi: 10.18632/oncotarget.24690.
Authors
Philip Carter
1
,
Costi Alifrangis
2
,
Pramodh Chandrasinghe
1
3
4
,
Biancastella Cereser
1
,
Lisa Del Bel Belluz
1
,
Cosimo Alex Leo
4
,
Nina Moderau
1
,
Neha Tabassum
1
,
Janindra Warusavitarne
4
,
Jonathan Krell
1
,
Justin Stebbing
1
Affiliations
1
Department of Surgery and Cancer, Imperial College, London, UK.
2
Department of Medical Oncology, Imperial College, London, UK.
3
Department of Surgery, University of Kelaniya, Kelaniya, Sri Lanka.
4
Department of Colorectal Surgery, St Mark's Hospital, London, UK.
PMID:
29601069
PMCID:
PMC5871108
DOI:
10.18632/oncotarget.24690
Abstract
[This corrects the article DOI: 10.18632/oncotarget.24257.].
Publication types
Published Erratum
Grants and funding
MR/L000172/1/MRC_/Medical Research Council/United Kingdom
NIHR-RP-011-053/DH_/Department of Health/United Kingdom